Clinical Trial Update: Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a combination of cetuximab, docetaxel, cisplatin, and radiation therapy for locally advanced, surgically resectable esopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED